• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

rs41291957 控制 miR-143 和 miR-145 的表达,并影响冠心病的风险。

rs41291957 controls miR-143 and miR-145 expression and impacts coronary artery disease risk.

机构信息

Humanitas Research Hospital-IRCCS, Rozzano, Italy.

Institute of Genetics and Biomedical Research, National Research Council, Rozzano, Italy.

出版信息

EMBO Mol Med. 2021 Oct 7;13(10):e14060. doi: 10.15252/emmm.202114060. Epub 2021 Sep 22.

DOI:10.15252/emmm.202114060
PMID:34551209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8495461/
Abstract

The role of single nucleotide polymorphisms (SNPs) in the etiopathogenesis of cardiovascular diseases is well known. The effect of SNPs on disease predisposition has been established not only for protein coding genes but also for genes encoding microRNAs (miRNAs). The miR-143/145 cluster is smooth muscle cell-specific and implicated in the pathogenesis of atherosclerosis. Whether SNPs within the genomic sequence of the miR-143/145 cluster are involved in cardiovascular disease development is not known. We thus searched annotated sequence databases for possible SNPs associated with miR-143/145. We identified one SNP, rs41291957 (G > A), located -91 bp from the mature miR-143 sequence, as the nearest genetic variation to this miRNA cluster, with a minor allele frequency > 10%. In silico and in vitro approaches determined that rs41291957 (A) upregulates miR-143 and miR-145, modulating phenotypic switching of vascular smooth cells towards a differentiated/contractile phenotype. Finally, we analysed association between rs41291957 and CAD in two cohorts of patients, finding that the SNP was a protective factor. In conclusion, our study links a genetic variation to a pathological outcome through involvement of miRNAs.

摘要

单核苷酸多态性(SNPs)在心血管疾病的病因发病机制中的作用是众所周知的。不仅在编码蛋白质的基因中,而且在编码 microRNA(miRNA)的基因中,SNP 对疾病易感性的影响也已经确定。miR-143/145 簇是平滑肌细胞特异性的,与动脉粥样硬化的发病机制有关。miR-143/145 簇基因组序列内的 SNP 是否参与心血管疾病的发展尚不清楚。因此,我们在注释序列数据库中搜索与 miR-143/145 相关的可能 SNP。我们确定了一个 SNP,rs41291957(G>A),位于成熟 miR-143 序列的-91bp 处,是该 miRNA 簇最近的遗传变异,其次要等位基因频率>10%。计算机模拟和体外方法确定 rs41291957(A)上调 miR-143 和 miR-145,调节血管平滑肌细胞向分化/收缩表型的表型转换。最后,我们在两个患者队列中分析了 rs41291957 与 CAD 之间的关联,发现该 SNP 是一个保护因素。总之,我们的研究通过 miRNA 的参与将遗传变异与病理结果联系起来。

相似文献

1
rs41291957 controls miR-143 and miR-145 expression and impacts coronary artery disease risk.rs41291957 控制 miR-143 和 miR-145 的表达,并影响冠心病的风险。
EMBO Mol Med. 2021 Oct 7;13(10):e14060. doi: 10.15252/emmm.202114060. Epub 2021 Sep 22.
2
Role of miR-143 and miR-146 in Risk Evaluation of Coronary Artery Diseases in Autopsied Samples.miR-143 和 miR-146 在尸检样本中冠状动脉疾病风险评估中的作用。
Genes (Basel). 2023 Feb 12;14(2):471. doi: 10.3390/genes14020471.
3
A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression.一个常见的 miR-146 前体变异与冠状动脉疾病风险及其成熟 miRNA 表达相关。
Mutat Res. 2014 Mar;761:15-20. doi: 10.1016/j.mrfmmm.2014.01.001. Epub 2014 Jan 19.
4
Molecular Evaluation of MicroRNA-146 Gene Variability (rs2910164 C> G) and its Association with Increased Susceptibility to Coronary Artery Disease.miR-146 基因变异(rs2910164 C>G)的分子评估及其与冠心病易感性增加的关联。
Microrna. 2020;9(5):363-372. doi: 10.2174/2211536609666201209151130.
5
Potential risk assessment of miR-143 gene polymorphisms rs41291957 and rs353292 in colorectal cancer.miR-143 基因多态性 rs41291957 和 rs353292 与结直肠癌潜在风险的评估。
Cell Mol Biol (Noisy-le-grand). 2020 Oct 31;66(7):169-173.
6
Influence of genetic polymorphisms in DICER and XPO5 genes on the risk of coronary artery disease and circulating levels of vascular miRNAs.DICER 和 XPO5 基因遗传多态性对冠心病风险及循环血管 miRNA 水平的影响。
Thromb Res. 2019 Aug;180:32-36. doi: 10.1016/j.thromres.2019.05.021. Epub 2019 Jun 3.
7
No association of pri-miR-143 rs41291957 polymorphism with the risk of congenital heart disease in a Chinese population.在中国人群中,pri-miR-143 rs41291957多态性与先天性心脏病风险无关联。
Pediatr Cardiol. 2014 Aug;35(6):1057-61. doi: 10.1007/s00246-014-0898-2. Epub 2014 Apr 22.
8
MiR-135b-5p and MiR-499a-3p Promote Cell Proliferation and Migration in Atherosclerosis by Directly Targeting MEF2C.MiR-135b-5p和MiR-499a-3p通过直接靶向MEF2C促进动脉粥样硬化中的细胞增殖和迁移。
Sci Rep. 2015 Jul 17;5:12276. doi: 10.1038/srep12276.
9
Functional Analysis of a Novel Genome-Wide Association Study Signal in SMAD3 That Confers Protection From Coronary Artery Disease.SMAD3中一个新的全基因组关联研究信号的功能分析,该信号赋予对冠状动脉疾病的保护作用。
Arterioscler Thromb Vasc Biol. 2016 May;36(5):972-83. doi: 10.1161/ATVBAHA.116.307294. Epub 2016 Mar 10.
10
Two Single Nucleotide Polymorphisms (rs2431697 and rs2910164) of miR-146a Are Associated with Risk of Coronary Artery Disease.微小RNA-146a的两个单核苷酸多态性(rs2431697和rs2910164)与冠状动脉疾病风险相关。
Int J Environ Res Public Health. 2017 May 10;14(5):514. doi: 10.3390/ijerph14050514.

引用本文的文献

1
Natural Bioproducts with Epigenetic Properties for Treating Cardiovascular Disorders.具有表观遗传特性的天然生物制品用于治疗心血管疾病。
Genes (Basel). 2025 May 10;16(5):566. doi: 10.3390/genes16050566.
2
Associations of microRNA Gene Polymorphisms With Salt Sensitivity, Longitudinal Blood Pressure Changes, and Hypertension Incidence in the Chinese Population.中国人群中微小RNA基因多态性与盐敏感性、血压纵向变化及高血压发病率的关联
J Clin Hypertens (Greenwich). 2025 Feb;27(2):e70019. doi: 10.1111/jch.70019.
3
Single nucleotide polymorphisms: Implications in the early diagnosis and targeted intervention of coronary microvascular dysfunction.

本文引用的文献

1
miR-128-3p Is a Novel Regulator of Vascular Smooth Muscle Cell Phenotypic Switch and Vascular Diseases.miR-128-3p 是血管平滑肌细胞表型转换和血管疾病的新型调节因子。
Circ Res. 2020 Jun 5;126(12):e120-e135. doi: 10.1161/CIRCRESAHA.120.316489. Epub 2020 Mar 27.
2
Potential Impact of MicroRNA Gene Polymorphisms in the Pathogenesis of Diabetes and Atherosclerotic Cardiovascular Disease.微小RNA基因多态性在糖尿病和动脉粥样硬化性心血管疾病发病机制中的潜在影响
J Pers Med. 2019 Nov 25;9(4):51. doi: 10.3390/jpm9040051.
3
Epigenetics and vascular diseases.
单核苷酸多态性:对冠状动脉微血管功能障碍早期诊断及靶向干预的意义
Genes Dis. 2024 Feb 28;12(2):101249. doi: 10.1016/j.gendis.2024.101249. eCollection 2025 Mar.
4
The role of Sertoli cell-derived miR-143-3p in male fertility declines with age.睾丸支持细胞衍生的miR-143-3p在男性生育能力中的作用随年龄增长而下降。
Mol Ther Nucleic Acids. 2024 Oct 28;35(4):102369. doi: 10.1016/j.omtn.2024.102369. eCollection 2024 Dec 10.
5
Genetic Associations of Plasminogen Activator Inhibitor-1-Related miRNA Variants with Coronary Artery Disease.纤溶酶原激活物抑制剂-1 相关 miRNA 变异与冠状动脉疾病的遗传关联。
Int J Mol Sci. 2024 Oct 27;25(21):11528. doi: 10.3390/ijms252111528.
6
Therapeutic Potential of Natural Compounds Acting through Epigenetic Mechanisms in Cardiovascular Diseases: Current Findings and Future Directions.天然化合物通过表观遗传机制在心血管疾病中的治疗潜力:当前的发现和未来的方向。
Nutrients. 2024 Jul 24;16(15):2399. doi: 10.3390/nu16152399.
7
A Review of MicroRNAs and lncRNAs in Atherosclerosis as Well as Some Major Inflammatory Conditions Affecting Atherosclerosis.微小RNA和长链非编码RNA在动脉粥样硬化以及影响动脉粥样硬化的一些主要炎症性疾病中的研究综述
Biomedicines. 2024 Jun 13;12(6):1322. doi: 10.3390/biomedicines12061322.
8
Endothelial to mesenchymal transition: at the axis of cardiovascular health and disease.内皮细胞向间充质细胞转化:在心血管健康和疾病的轴心处。
Cardiovasc Res. 2024 Mar 14;120(3):223-236. doi: 10.1093/cvr/cvae021.
9
Therapeutic Potential of EVs: Targeting Cardiovascular Diseases.细胞外囊泡的治疗潜力:针对心血管疾病
Biomedicines. 2023 Jul 6;11(7):1907. doi: 10.3390/biomedicines11071907.
10
Role of miR-143 and miR-146 in Risk Evaluation of Coronary Artery Diseases in Autopsied Samples.miR-143 和 miR-146 在尸检样本中冠状动脉疾病风险评估中的作用。
Genes (Basel). 2023 Feb 12;14(2):471. doi: 10.3390/genes14020471.
表观遗传学与血管疾病。
J Mol Cell Cardiol. 2019 Aug;133:148-163. doi: 10.1016/j.yjmcc.2019.06.010. Epub 2019 Jun 15.
4
Circ_Lrp6, a Circular RNA Enriched in Vascular Smooth Muscle Cells, Acts as a Sponge Regulating miRNA-145 Function.环状 RNA Lrp6 在血管平滑肌细胞中富集,作为一种海绵调节 miRNA-145 的功能。
Circ Res. 2019 Feb 15;124(4):498-510. doi: 10.1161/CIRCRESAHA.118.314240.
5
Genetic Regulatory Mechanisms of Smooth Muscle Cells Map to Coronary Artery Disease Risk Loci.平滑肌细胞的遗传调控机制与冠状动脉疾病风险基因座相关。
Am J Hum Genet. 2018 Sep 6;103(3):377-388. doi: 10.1016/j.ajhg.2018.08.001. Epub 2018 Aug 23.
6
UHRF1 epigenetically orchestrates smooth muscle cell plasticity in arterial disease.UHRF1 通过表观遗传调控动脉疾病中的平滑肌细胞可塑性。
J Clin Invest. 2018 Jun 1;128(6):2473-2486. doi: 10.1172/JCI96121. Epub 2018 May 7.
7
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.脂蛋白(a)浓度、LPA 遗传变异与已确诊冠心病患者死亡风险的关系:一项分子遗传学关联研究。
Lancet Diabetes Endocrinol. 2017 Jul;5(7):534-543. doi: 10.1016/S2213-8587(17)30096-7. Epub 2017 May 26.
8
Epigenetics and Vascular Diseases: Influence of Non-coding RNAs and Their Clinical Implications.表观遗传学与血管疾病:非编码RNA的影响及其临床意义
Front Cardiovasc Med. 2017 Apr 27;4:26. doi: 10.3389/fcvm.2017.00026. eCollection 2017.
9
Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease.循环 miR-155、miR-145 和 let-7c 作为冠心病的诊断生物标志物。
Sci Rep. 2017 Feb 16;7:42916. doi: 10.1038/srep42916.
10
A Functional rs353293 Polymorphism in the Promoter of miR-143/145 Is Associated with a Reduced Risk of Bladder Cancer.miR-143/145启动子区功能性rs353293多态性与膀胱癌风险降低相关。
PLoS One. 2016 Jul 20;11(7):e0159115. doi: 10.1371/journal.pone.0159115. eCollection 2016.